Compare ORMP & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | MPV |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 169.4M |
| IPO Year | 2010 | N/A |
| Metric | ORMP | MPV |
|---|---|---|
| Price | $4.66 | $16.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 191.6K | 22.4K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | 6.51% | ★ 8.71% |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 2.76 | 1.71 |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.69 | $9.99 |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $2.09 | $15.05 |
| 52 Week High | $5.47 | $20.58 |
| Indicator | ORMP | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 57.48 |
| Support Level | $3.91 | $16.05 |
| Resistance Level | $5.10 | $17.38 |
| Average True Range (ATR) | 0.18 | 0.33 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 21.31 | 83.87 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.